AlphaMaven AlphaMaven

Private equity’s insurance love affair – can value outlast the deal?

Reported by Insurancetimes
Oct 28, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • MarshBerry data shows 60 UK insurance distribution transactions announced by end-September 2026, down 22% from 77 at the same stage in 2025, yet deal values surged with more than £3bn of transactions completed during the year.
  • • Specialty businesses accounted for just 28% of 2026 transaction volume but more than 85% of total deal value, according to MarshBerry, pushing PE investors toward MGAs and underwriting-focused platforms.
  • • EQT's reported $2bn acquisition of a majority stake in McGill and Partners from Warburg Pincus in September illustrates continued appetite for specialty insurance platforms.
  • • Industry voices including Inflexion's Andrea Bertolini and MarshBerry's John Nisbet say the 'indiscriminate buy and build' model is over, with investors now judged on organic growth and operational improvement after deal close.
  • • Experts warn that growth ambitions exceeding an MGA's historical underwriting performance can undermine the qualities that created value, and that changes in ownership may affect capacity partnerships and commission arrangements.
Summary
Private equity's role in UK insurance distribution is shifting from acquisition-led expansion toward a test of whether investors can build better businesses rather than simply larger ones, according to Insurance Times. MarshBerry data cited in the article shows 60 UK insurance distribution transactions had been announced by the end of September 2026, down 22% from 77 deals at the same stage in 2025. Deal values nonetheless rose sharply, with more than £3bn of transactions completed during the year and specialty businesses accounting for the overwhelming majority of value.

Industry participants describe a more selective market. Andrea Bertolini, partner and head of financial services at Inflexion, said that 'buy and build cannot be a substitute for organic growth,' noting that insurance broking has long appealed to PE for its recurring commission revenue, resilient earnings and fragmented market. John Nisbet, managing director at MarshBerry, said 'the indiscriminate buy and build is over,' adding that investors increasingly want evidence of genuine operational progress. Rizwan Rahman, partner at CMS, said prospective buyers are asking whether the consolidated business will operate better, warning that acquiring regulated businesses purely for scale can create costs and regulatory challenges.

MGAs have become increasingly attractive as traditional broking consolidates. The article cites EQT's reported $2bn acquisition of a majority stake in McGill and Partners from Warburg Pincus in September as an example of continuing investor appetite for underwriting-focused platforms. MGAs give insurers access to specialist underwriting knowledge and distribution, and Rahman said such flexibility is especially valuable in fast-moving areas such as cyber insurance.

The article also highlights tensions within the model. MGA value depends on underwriting discipline, and growth achieved at the expense of profitability can erode the business investors intended to strengthen. Nisbet raised 'question marks over the alignment between private equity and long-term sustainable underwriting performance.' Tim Jones, director at MPR Underwriting, said growth should follow good underwriting rather than drive it, and that tension is most likely where investor growth ambitions exceed what an MGA has consistently achieved. Jones also cautioned that a change in ownership could affect capacity-provider relationships and commission arrangements.

Supporters argue PE capital funds technology, compliance and governance that smaller firms might struggle to finance, while critics question whether return pressure conflicts with longer-term priorities. The article notes there is little evidence that PE ownership systematically improves or worsens customer outcomes. It concludes that PE is unlikely to disappear from insurance distribution, but that a successful exit shows a business has become more valuable without proving it has become better.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Insurancetimes Private equity’s insurance love affair – can value outlast the deal?